The government levy on prescription drugs in Scotland has been cut by 20% from GBP5 ($7.40) to GBP4, effective from April, with the commitment of the Scottish Parliament to abolish the charge altogether by 2011. With the tax previously scrapped in Wales (Marketletters passim) and due to be eliminated in Northern Ireland next year, this means that England, where the prescription charge has risen from GBP7.10 to GBP7.20, is the only part of the UK where National Health Service patients pay towards their medicines.
The UK's public broadcaster, the BBC, reports that cancer patients will be exempt from paying an Rx charge throughout the UK from the current year, although the lack of provision of newer treatments following a spate of negative rulings by the National Institute for Health and Clinical Excellence (NICE) means that patients may have to top up by paying private sector rates for drugs, a practice which was only made legal in England late last year (Marketletter November 10, 2008), with Scotland following in December (Marketletter December 22, 2008).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze